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Background: Wnt signaling in the colon cancer tumor microenvironment (TME) may affect cancer biologic
properties including invasion and metastatic dissemination. Prior reports have suggested that the expression of
select frizzled (Fz) receptors may be altered in cancers and in the TME.
Methods: Colon cancer, colonic adenoma and normal colonic mucosal specimens were obtained under
institutional review board approval and analyzed for the expression of Fz1 and Fz2 by confocal fluorescent
immunohistochemistry and Wnt-specific membrane array. In vitro, the effect of Wnt3a on Fz1 expression was
examined in normal-derived NCM460 cells by qRT-PCR and immunohistochemistry.
Results: Fz1 was expressed in colon cancer and villous adenomas but not in more benign tubular adenomas. Fz1
expression was seen in normal colonic mucosa in close proximity to colon cancer, but not villous or tubular
adenomas. Normal colonic mucosa distant from colon cancer did not express Fz1. Fz2 was expressed ubiquitously
in cancer, adenomas and normal colonic mucosa. Fz1 expression was induced by Wnt3a in a normal colon
mucosa-derived cell line in vitro.
Conclusions: Fz1 is a Wnt responsive gene in colon-derived tissues. Fz1 expression exhibited increased expression
in normal mucosa only in close proximity to colon cancer. This field effect was not seen with pre-malignant
adenomas and may be due to Wnt/β-catenin signaling within the TME. Fz1 may represent a new TME-directed
therapeutic target for patients with colon cancer.
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There is increasing recognition that tumor biology is
modulated by signals derived from, and received by cells
within the tumor microenvironment (TME) [1]. Interactions
with non-transformed cells in the TME may facilitate inva-
sion and metastases, or, alternatively, inhibit tumor progres-
sion. Enhanced Wnt pathway signaling has been recognized
as a hallmark of colon cancer with over 85% of these malig-
nancies harboring mutations within the pathway that lead to
constitutive activation [2]. However, the strength of the Wnt* Correspondence: randall.holcombe@mssm.edu
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reproduction in any medium, provided the orsignal is modulated by factors within the TME, including
Wnt ligands which augment canonical Wnt signaling and
soluble inhibitors which suppress it [3,4].
Wnt activity in colon cancer stem cells is modulated by
myofibroblast-secreted factors in the TME [5] and other
stromal cells may similarly regulate Wnt activity in colon
cancer in a paracrine fashion [6]. Interactions of malignant
with stromal cells may affect Wnt signaling directly [7] or
via autocrine feedback loops [8] from tumor cells
overexpressing secreted Wnt ligands [9]. The invasion mar-
gin of colon cancer is characterized by nuclear b-catinin
suggesting increased Wnt pathway activation at the cancer:
stroma interface [10]. While most studies have focused on
the effects of stroma on the biologic behavior of the cancerl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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tumor stroma, with subsequent secondary effects on cancer
invasion and progression [11].
Frizzled receptors are 7-transmembrane proteins which
serve, in conjunction with LRP5/6 co-receptors as the
binding partners for extracellular Wnt ligands to initiate
the Wnt signal. Conceptually, the signals transduced pro-
gress along one of two intracellular pathways – canonical,
resulting ultimately in the accumulation of β-catenin in
the nucleus where it promotes transcriptional activation
in conjunction with the LEF/TCF family of DNA binding
proteins and non-canonical, resulting in activation of pro-
tein kinase C, c-Jun-N-terminal kinases or calcium/cal-
modulin-dependent kinases. However, Wnt signaling is
significantly more complex as there is crosstalk between
canonical and non-canonical pathways, and ligands and
receptors may result in differential signaling in a context-
dependent fashion [12].
Few studies have examined the role of distinct frizzled
receptors in the TME. Factors in the TME have been
implicated in the regulation of Fz7 on colorectal cancer cells
[13] and Fz7 downregulation has been linked to reduced
survival, invasion and metastatic potential [14], suggesting
that Fz7 may represent a therapeutic target. In this report,
we describe the differential expression of Fz1 in the colon
cancer TME and provide evidence of autocrine regulation in
tumor cells and paracrine regulation by factors within the
TME on Fz1 expression in non-malignant mucosal epithe-
lium, as well as lack of paracrine regulation in proximity to
pre-malignant colon adenomas. To our knowledge, this is
the first report of a field effect of a specific frizzled receptor
in the colon tumor microenvironment.
Materials and methods
Tissue acquisition
Over 20 distinct de-identified colon cancer and corresponding
normal colonic mucosa was obtained from archived
specimens at UCIrvine under a non-human subjects
exemption by the UCIrvine institutional review board.
Adenoma specimens with biopsies of corresponding
normal mucosa were obtained from 12 different patients
following informed consent under a UCIrvine institutional
review board approved protocol from patients undergoing
elective colonoscopic screening as described previously
[15]. All research was performed in compliance with the
Declaration of Helsinki.
Cell culture
The NCM460 cell line was purchased from INCELL
Corporation (San Antonio, TX, USA) and cultured in M3
media supplemented with 10% FBS, 100 U/ml penicillin and
100 mg/ml streptomycin at 37°C in a 95% humidified
atmosphere with 5% CO2. This epithelial cell line was
derived from normal colonic mucosa and is not tumorigenic though, over time in culture it has acquired some
transformation-associated characteristics [16]. NCM460 is
not transfected with any exogenous genetic information.
WNT3a conditioned medium (CM)
Wnt3a CM and control CM were prepared using the
LWnt3A cell line (ATCC#CRL-2647) and the parental
cell line (ATCC #CRL-2648) according to procedures
perfected in the laboratory of Dr. Roel Nusse [17]; for a
preparation protocol, see http://www.stanford.edu/group/
nusselab/cgi-bin/wnt/. Cells were analyzed after 24 h of
Wnt3a treatment for Fz1 expression.
Immunohistochemistry
Immunohistochemistry for Fz1 and Fz2 were performed
with specific anti-Fz1 antibodies (Genentech, Inc.,
#GTX71477) and anti-Fz2 antibodies, (Genentech, Inc.
#GTX71817), 1 mg/ml, at 1:200 dilution. Paraffin-
imbedded slides were deparaffinized and sodium cit-
rate buffer pH 6 20 min at 99°C was used as an antigen
retrieval agent. Santa Cruz Biotechnology rabbit ABC
Staining System (SC-2018) was used according to the
manufacturer’s protocol, and the signal was amplified
by TSA™ Fluorescein Tyramide Reagent from Perkin
Elmer (SAT701001EA). Slides were stained with DAPI
and covered with anti-fade embedding medium (Pro-
Long Gold antifade reagent, Invitrogen P36934). Con-
focal microscopy was performed with a Carl Zeiss
LSM 510 and 40x fluorescent objective.
Quantitative real-time polymerase chain reaction (qRT-PCR)
Fz1 expression in NCM460 was determined by qRT-
PCR with Fz1 specific primers. The efficiency of the Fz1
and actin primers was equivalent. Primer pairs were
obtained from Qiagen (Valencia, CA) with cycling
parameters as defined by the manufacturer. For qRT-
PCR experiments, the relative RNA expression was
calculated by the comparative threshold cycle method.
Wnt-specific membrane array
Fz1 mRNA expression in adenomas and normal mucosa
was defined with cDNA generated from tissue-derived
RNA and analyzed with a GEArray Q Series Human Wnt
Signaling Pathway Gene Array (SuperArray Bioscience,
Frederick, MD). GEArray expression analysis software
was utilized for background normalization, correction
for different degrees of exposure, and normalization
with multiple housekeeping gene controls on each
membrane.
Statistical analysis
Fz1 mRNA and protein expression in NCM460 cells
was compared with an unpaired t-test between experi-
mental (Wnt3a CM) and control (L-Cell CM) groups.
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3 groups by 1-way ANOVA with a post-hoc Newman
Kuels test. Individual subgroups were also compared by
unpaired t-test.
Results
Expression of Fz1 and Fz2 receptors in colon cancer
tumor microenvironment
Fluorescent immunohistochemistry with specific anti-
Fz1 and anti-Fz2 antibodies was performed on tissue
sections from colon cancer, adjacent normal colonicFigure 1 Expression of frizzled receptors by fluorescent immunohisto
in colon cancer – DAPI (A), anti-Fz1 antibody (B), merged images (C) – sho
colonic mucosa distant (>2 cm) from colon cancer – DAPI (D), anti-Fz1 ant
Panels G, H, I: Fz1 expression in normal colonic mucosa adjacent to colon
significant Fz1 expression. Panels J, K, L: Fz2 expression in colon cancer – D
expression. Panels M, N, O: Fz2 expression in normal colonic mucosa distan
merged images (O) – showing uniform expression. Panel P: Composite of m
colonic mucosa adjacent to tumor showing expression in both the cancer
immunohistochemistry with anti-Fz1/(2) antibody of colon cancer, normal
mucosa distant from the tumor (insert) showing significant expression in th
magnification from image displayed in Panel Q of normal colonic mucosa
magnification from image displayed in Panel Q of normal colonic mucosamucosa and distant normal colonic mucosa. All
experiments included secondary antibody only controls
on sequential tissue sections. Fz1 and Fz2 were both
expressed in colon cancer tissues. Fz1 was detected in
histologically normal mucosa in close proximity to the
neoplastic cells (see Figure 1, panels H and P). The normal
mucosa examined was adjacent to an invasive margin of
the tumor. More distant from the tumor, however, Fz1 ex-
pression was not seen in normal mucosa demonstrating a
field effect in the tumor microenvironment with respect
to expression of this specific Wnt receptor. In contrast,chemistry in patient derived samples. Panels A, B, C: Fz1 expression
wing uniform expression. Panels D, E, F: Fz1 expression in normal
ibody (E), merged images (F) – showing lack of significant expression.
cancer – DAPI (G), anti-Fz1 antibody (H), merged images (I) – showing
API (J), anti-Fz2 antibody (K), merged images (L) – showing uniform
t (>2 cm) from colon cancer – DAPI (M), anti-Fz2 antibody (N),
ultiple merged images of Fz1 expression in colon cancer and normal
and in the adjacent normal mucosa. Scale bar = 50 um. Panel Q: DAB
colonic mucosa adjacent to the tumor (arrows) and normal colonic
e cancer and in the adjacent normal colonic mucosa. Panel R: Higher
adjacent to colon cancer showing expression. Panel S: Higher
distant from colon cancer showing lack of expression.
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in addition to its expression in colon cancer.Induction of Fz1 expression in vitro
In tissue culture, normal colon-derived NCM460 cells
were evaluated for expression of cell surface Fz1 in response
to exogenous Wnt ligand Wnt3a. These experiments dem-
onstrate that Fz1 is a Wnt-responsive gene, with increased
expression in response to Wnt3a. The Wnt3a response was
manifested by both an increase in Fz1 mRNA (p<0.005;
Figure 2, panel A) and Fz1 protein (light intensity, p<0.001;
Figure 2, panel D), suggesting that enhanced transcription is
the primary mechanism leading to increased Fz1 expression
in response to Wnt3a.Figure 2 Response of Fz1 expression to exogenous Wnt3a ligand in n
quantitative real-time PCR without and with 24 h of exposure to Wnt3a. p<
Panels B, C: Fluorescent immunohistochemistry of NCM460 cells in tissue c
Quantified light intensity from immunofluorescence of anti-Fz1 antibody st
p<0.001 for the difference (3 independent experiments with 25 individual fExpression of Fz1 in colonic adenomas
Colonic adenomas were evaluated for Fz1 expression
in order to define the stage in the neoplastic progression
where Fz1 expression begins and whether the field effect
for Fz1 noted in normal mucosa adjacent to colon can-
cer is specific for invasive carcinoma. Using a Wnt spe-
cific membrane array, Fz1 mRNA could be detected at
low levels in both normal colonic mucosa and tubular
adenomas. However, Fz1 mRNA was markedly increased
in villous adenomas in comparison to normal mucosa
and tubular adenomas (p=0.0176 1 way ANOVA, p<0.05
Newman-Kuels for both comparisons; p=0.024 villous
vs. tubular by unpaired t-test; p=0.012 villous vs. normal
by unpaired t-test). Villous adenomas have a substan-
tially higher malignant potential than tubular adenomas.ormal colon-derived NCM460 cells. Panel A: mRNA levels by
0.005 for the difference (3 separate experiments, all in triplicate).
ulture without (B) and with (C) 24 h of exposure to Wnt3a. Panel D:
aining in NCM460 cells without and with 24 h of exposure to Wnt3a.
ields recorded for each).
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expression (Figure 3, panels G and H) but no expression
was detected in normal mucosa or tubular adenomas,
suggesting that the molecular switch or conditions
within the tumor microenvironment permissive for Fz1
expression occur in the transition from tubular to villous
histologies.. In contrast to what was seen with invasive
colon cancer, however, no field effect of the expression
of Fz1 was seen in close proximity to non-invasive aden-
omas (Figure 3, panel I), including villous adenomas
which themselves expressed Fz1 protein.
Discussion/conclusions
The expression of the Wnt pathway receptors Fz1 and Fz2
has been previously implicated in cancer development andFigure 3 Expression of Fz1 in colonic adenomas. Panel A: mRNA levels
adenoma and villous adenomas (N=12). p=0.0176 (1 way ANOVA) with p<
villous vs. tubular; p=0.024 villous vs. tubular (unpaired Student’s t test); p=
colonic mucosa – secondary antibody only (B) and merged images (C) - sh
D, E: Tubular adenoma – secondary antibody only (D) and merged images
DAPI. Panel F, G, H: Villous adenomas – secondary antibody only (F) and 2
Staining with anti-Fz1 (G, H) antibody demonstratesFz1 expression. All pan
mucosa adjacent to villous adenoma showing lack of Fz1 expression.progression. Their expression is reported to be increased
in breast cancer in comparison to normal breast epithe-
lium [18]. There is also prior evidence using older, less
specific antibodies that Fz1 or Fz2 expression is increased
at the invasion margin of poorly differentiated colon can-
cer [9]. Fz1 mediates Wnt/β-catinin (canonical) signaling
in neuroblastoma [19] and serves as a receptor for Wnt3a
in both macrophages [20] and pheochromocytoma-
derived PC12 cells [21]. In both these latter systems,
Wnt3a/Fz1 interactions induce signaling along the canon-
ical Wnt pathway. However, there is one report that Fz1 is
antagonistic of Wnt/β-catinin signaling in a Xenopus cap
assay and secondary axis formation assay [22], suggesting
that the specific activity of Fz1 may be context dependent.
The role of Fz2 is less well studied though it appears toby Wnt specific membrane array in normal colonic mucosa, tubular
0.05 by Newman-Kuels post hoc analysis for villous vs. normal and
0.012 villous vs. normal (unpaired Student’s t test). Panel B, C: Normal
owing lack of Fz1 expression. Both panels co-stained with DAPI. Panel
(E) - showing lack of Fz1 expression. Both panels co-stained with
merged images (G, H) of villous adenomas from different patients.
els co-stained with DAPI. Panel I: Merged image of normal colonic
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naling and Wnt5a which inhibits it [23].
What is clear from this report is that Fz1 expression is
tightly regulated in the tumor microenvironment. As
both an effector molecule for Wnt signaling and also, as
we have shown here, as a Wnt responsive gene, Fz1 may
function as part of a positive autocrine feedback loop in
colon cancer cells. Whether this effect is limited to
Wnt3a which promotes Fz1 transcription and to which
Fz1 also binds requires further study. In the tumor
microenvironment, a field effect of Fz1 expression exists
suggesting paracrine regulation of this receptor. Fz1 ex-
pression on normal colonic mucosa within the TME is
induced by cancer but not by non-invasive adenomas,
including villous adenomas which themselves express
Fz1. We speculate that this is related to the degree of
Wnt, and particularly Wnt3a ligand production by the
colon cancer cells. Increased nuclear localization of β-
catenin at the invasion front is a characteristic of colon
cancer [24] and colon cancer is known to have increased
expression of various Wnt ligands [9]. While this prior
work demonstrated differences in Wnt ligand expression
between tumor and normal tissues, whether a gradient
of Wnt3A expression within the tumors exists, possibly
increased at the invasion margin, has not been
investigated. Differences in the level of Wnt activity
within tumors may occur, with a high activity of the
Wnt pathway is observed in tumour cells located close
to stromal myofibroblasts, implicating signals from the
stroma may be involved [5]. Secreted factors other than
Wnt ligands may also be important. For example, Suzuki
and colleagues [25] have reported that epigenetic inacti-
vation of SFRP genes leads to augmented Wnt signaling
in colon cancer and this process may not be operative in
pre-malignant adenomas. Lack of nuclear translocation
of β-catenin in sporadic adenomas, in contract to cancer,
has been described previously [26]. Finally, expression of
Fz1, as well as Fz6 and Fz7, are positively correlated with
Wnt/β-catenin signaling in human mesenchymal cells
[27] further suggesting that the regulated expression of
Fz1 in the tumor microenvironment is a function of, and
contributes to, Wnt signaling in the tumor:stromal
mileau. While no morphologic change in the composition
of stroma was identified in our study, experiments were
not designed to specifically detect this. Stromal cell re-
cruitment at tumor sites has been described previously
[28]. Further investigations will be needed to define
whether Fz1 and Wnt signaling play a role in this process.
In addition to its expression in colon cancer, Fz1 ex-
pression appears to be confined to pre-malignant aden-
omas with villous features which represent the histologic
type of adenoma with greatest risk for malignant trans-
formation [29]. Development of rapid immunofluores-
cence techniques that can be performed in conjunctionwith advanced endoscopic imaging could potentially lead
to the use of Fz1 to differentiate villous from non-villous
adenomas in situ. This marker may also prove a useful
adjunct to routine histologic examination of colonic
adenomas.
The significance of Fz1 on normal colonic mucosa in
the TME requires further study. Given the known
functions of Wnt/β-catinin signaling, it may promote
proliferation and block differentiation of colonic muco-
sal cells, promoting tumor invasion by accelerating mu-
cosal turnover. Fz1 expression in the TME may
modulate colon cancer progression and dissemination
and therefore may represent a new TME-directed thera-
peutic target for patients with colon cancer.
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